Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research
about
Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ)Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenRisedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenThe pharmacological management of osteoporosisBisphosphonates: mechanism of action and role in clinical practiceIntravenous zoledronate for osteoporosis: less might be moreTargeted Delivery Systems for Molecular Therapy in Skeletal DisordersPrevention and treatment of bone fragility in cancer patientManaging Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral ResearchOsteochemonecrosis: an overviewThe evolution of selective estrogen receptor modulators in osteoporosis therapyTargeting bone physiology for the treatment of metastatic prostate cancerBisphosphonate drug holiday: choosing appropriate candidatesThe osteocyte as a therapeutic target in the treatment of osteoporosisSkeletal complications of bisphosphonate use: what the radiologist should knowEpidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonate-related osteonecrosis of the jawsIncreasing options for the treatment of osteoporosis2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary2014 Female Athlete Triad Coalition Consensus Statement on Treatment and Return to Play of the Female Athlete Triad: 1st International Conference held in San Francisco, California, May 2012 and 2nd International Conference held in Indianapolis, Indi"Phossy Jaw" and "Bis-phossy Jaw" of the 19th and the 21st Centuries: The Diuturnity of John Walker and the Friction MatchDiabetes, bone and glucose-lowering agents: clinical outcomes.Novel advances in the treatment of osteoporosis.Recent advances in the pathogenesis and treatment of osteoporosisThe management of osteoporosis in children.Practical considerations for treatment of patients taking bisphosphonate medications: an update.Prospects for osteoprogenitor stem cells in fracture repair and osteoporosisCancer treatment-related bone disease.Molecular mechanisms and treatment of bone metastasis.Existing data sources for clinical epidemiology: Scandinavian Cohort for osteonecrosis of the jaw - work in progress and challenges.Evaluation of fracture risk and potential drug holidays for postmenopausal women on long-term bisphosphonate therapyA network modeling approach for the spatial distribution and structure of bone mineral contentThe Tokyo Oldest Old survey on Total Health (TOOTH): a longitudinal cohort study of multidimensional components of health and well-being.Low-level laser therapy supported teeth extractions of two patients receiving IV zolendronate.Meaning and Limitation of Cortical Bone Width Measurement with DentaScan in Medication-Related Osteonecrosis of the Jaws.Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.Prevention of bone loss by zoledronic acid in premenopausal women undergoing adjuvant chemotherapy persist up to one year following discontinuing treatment.Bone health in the prostate cancer patient receiving androgen deprivation therapy: a review of present and future management options.A pilot case-control study on the alveolar bone density measurement in risk assessment for bisphosphonate-related osteonecrosis of the jaw.Patient perceptions of osteoporosis treatment thresholdsPaget's Disease: Skeletal Manifestations and Effect of Bisphosphonates.
P2860
Q24186105-C32E114A-5844-45F9-A502-E5EB623D007BQ24242258-83E5A701-E1C1-4D75-831A-4945CA39B81CQ24242674-A8AF236D-E17C-43A7-8DAA-5D776A0FA57FQ24605290-F417FD06-EF6D-4109-97D1-D583CBF89C6FQ24644708-5D2861C4-46EB-499D-8D14-2BD1A7045312Q26738958-BA2FC8DD-1C51-4DA8-9C4A-A7459F33B6DAQ26752158-B41EBC80-9F2A-4F1E-849F-70A28AADD8B2Q26775765-55C5A2F8-4578-4D79-ADEF-CEA866465933Q26782621-85FDC740-AAA9-4622-8DDC-66666060AEA4Q26827072-6635C24D-8EE1-4A04-829E-CF8AEFFE9834Q26827973-DEF26B88-4B22-487C-8BF9-3959A51A7C6DQ26863249-811C6A0F-98A3-422C-A4A3-E5693D5F8BB0Q27004682-4822DFAA-6757-4373-B48E-A55B9D76907AQ27009129-FECD1DDD-8776-4493-B3FB-E787791CEB74Q27010157-938652B9-AA65-4150-836E-958DE93673E0Q27025114-371DD6AF-B29D-4701-9400-C23E732BC645Q28254516-12266A00-D645-4C0A-889A-509C11E0624EQ28295416-09D3DE84-2D09-4D2D-A15F-26D335D0B695Q28306617-92B28D2F-F28A-4D59-A332-EFFF1009F914Q28601698-3D610453-39D9-43D9-AE4C-29C09DA24AA2Q30234622-B61DFC2A-478E-4481-8D56-AB247C27E737Q30248319-038B0191-83DB-46BC-A2EE-024262BCB009Q30248661-4DFBF813-96AC-4CF4-817A-35943E23B76FQ30251490-0F14410E-8F8E-4630-A96D-0399A866A3B1Q30405867-C357D5AC-15CF-4C34-BDE2-B85D4F58E7B0Q30431697-A6BC0A96-0B70-4C27-A7FE-3DA97C570ED1Q30438185-F2A801FA-CCF5-4CE6-8C78-083CFEDBD92DQ30445717-6C6DC2BF-3CF7-41A6-95F2-C0C4289341C7Q30888611-DD70F706-F545-4FA3-9E7A-AF596211C9A0Q33568586-0D20C9F2-5F2A-40C5-A342-F2BC46121FEFQ33574150-A7810EF9-F8B2-4625-8D1B-F32A66A0A72BQ33597136-C37AAA0B-F1CD-4289-B0DE-AF0C96E096DCQ33644664-02E1D0E0-889A-4604-A462-7298ED61E0D8Q33703167-B953792C-812E-4332-A003-C5E40BF6E880Q33715141-FDEA6F1A-2B1D-4079-9D39-32ADA41ED917Q33736180-04F48321-2C9C-4988-9A82-38B155FC59A5Q33754036-1F8431FD-52F0-4F1C-916C-9267B63D6B22Q33756363-D5E5150F-842D-4155-989C-26C342ACDDE4Q33766971-799FCA34-8B22-4EF1-9662-5A05779EE023Q33804865-949279B5-8624-4E65-802E-E07AADB53A63
P2860
Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research
description
article
@en
im Juli 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2007
@uk
name
Bisphosphonate-Associated Oste ...... for Bone and Mineral Research
@en
Bisphosphonate-Associated Oste ...... for Bone and Mineral Research
@nl
type
label
Bisphosphonate-Associated Oste ...... for Bone and Mineral Research
@en
Bisphosphonate-Associated Oste ...... for Bone and Mineral Research
@nl
prefLabel
Bisphosphonate-Associated Oste ...... for Bone and Mineral Research
@en
Bisphosphonate-Associated Oste ...... for Bone and Mineral Research
@nl
P2093
P2860
P50
P356
P1476
Bisphosphonate-Associated Oste ...... for Bone and Mineral Research
@en
P2093
Catherine H Van Poznak
David Burr
David G Pendrys
David M Shafer
David W Dempster
Dieter Felsenberg
Elizabeth Shane
Joan McGowan
Laurie K McCauley
Lawrence G Raisz
P2860
P304
P356
10.1359/JBMR.0707ONJ
P577
2007-07-19T00:00:00Z